Advertisement
Screener

Quest Diagnostics Inc (DGX) Capital Expenditures Incurred but Not yet Paid

1.9 / 5 stars · 46/120 Roast Me

Quest Diagnostics Inc Capital Expenditures Incurred but Not yet Paid

Quest Diagnostics Inc (DGX) reported Capital Expenditures Incurred but Not yet Paid of $46.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-23

  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $46.00M, a 24.32% increase year-over-year.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $40.00M, a 33.33% increase year-over-year.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $25.00M, a 0.00% change year-over-year.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $40.00M, a 14.29% increase year-over-year.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for fiscal 2025 was $65.00M, a 8.33% increase from fiscal 2024.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for fiscal 2024 was $60.00M, a 42.86% increase from fiscal 2023.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for fiscal 2023 was $42.00M, a 10.53% increase from fiscal 2022.
  • Quest Diagnostics Inc capital expenditures incurred but not yet paid for fiscal 2022 was $38.00M, a 46.15% increase from fiscal 2021.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 month
2026-06-30$46.00M
10-Q · filed 2026-07-23
$46.00M
10-Q · filed 2026-07-23
$111.00M
derived: sum of 3 quarters · filed 2026-07-23
$151.00M
derived: sum of 4 quarters · filed 2026-07-23
2026-03-31$40.00M
10-Q · filed 2026-04-22
$65.00M
derived: sum of 2 quarters · filed 2026-04-22
$105.00M
derived: sum of 3 quarters · filed 2026-04-22
$142.00M
derived: sum of 4 quarters · filed 2026-07-23
2025-12-31$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$65.00M
derived: sum of 2 quarters · filed 2026-02-26
$102.00M
derived: sum of 3 quarters · filed 2026-07-23
$65.00M
10-K · filed 2026-02-26
2025-09-30$40.00M
10-Q · filed 2025-10-21
$77.00M
derived: sum of 2 quarters · filed 2026-07-23
$40.00M
10-Q · filed 2025-10-21
$132.00M
derived: sum of 4 quarters · filed 2026-07-23
2025-06-30$37.00M
10-Q · filed 2026-07-23
$37.00M
10-Q · filed 2026-07-23
$92.00M
derived: sum of 3 quarters · filed 2026-07-23
$127.00M
derived: sum of 4 quarters · filed 2026-07-23
2025-03-31$30.00M
10-Q · filed 2026-04-22
$55.00M
derived: sum of 2 quarters · filed 2026-04-22
$90.00M
derived: sum of 3 quarters · filed 2026-04-22
$121.00M
derived: sum of 4 quarters · filed 2026-04-22
2024-12-31$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$60.00M
derived: sum of 2 quarters · filed 2026-02-26
$91.00M
derived: sum of 3 quarters · filed 2026-02-26
$60.00M
10-K · filed 2026-02-26
2024-09-30$35.00M
10-Q · filed 2025-10-21
$66.00M
derived: sum of 2 quarters · filed 2025-10-21
$35.00M
10-Q · filed 2025-10-21
$109.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$31.00M
10-Q · filed 2025-07-23
$31.00M
10-Q · filed 2025-07-23
$74.00M
derived: sum of 3 quarters · filed 2026-02-26
$101.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$28.00M
10-Q · filed 2025-04-23
$43.00M
derived: sum of 2 quarters · filed 2026-02-26
$70.00M
derived: sum of 3 quarters · filed 2026-02-26
$99.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$42.00M
derived: sum of 2 quarters · filed 2026-02-26
$71.00M
derived: sum of 3 quarters · filed 2026-02-26
$42.00M
10-K · filed 2026-02-26
2023-09-30$27.00M
10-Q · filed 2024-10-23
$56.00M
derived: sum of 2 quarters · filed 2024-10-23
$27.00M
10-Q · filed 2024-10-23
$86.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$29.00M
10-Q · filed 2024-07-24
$29.00M
10-Q · filed 2024-07-24
$59.00M
derived: sum of 3 quarters · filed 2025-02-20
$89.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$22.00M
10-Q · filed 2024-04-24
$30.00M
derived: sum of 2 quarters · filed 2025-02-20
$60.00M
derived: sum of 3 quarters · filed 2025-02-20
$83.00M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$38.00M
derived: sum of 2 quarters · filed 2025-02-20
$61.00M
derived: sum of 3 quarters · filed 2025-02-20
$38.00M
10-K · filed 2025-02-20
2022-09-30$30.00M
10-Q · filed 2023-10-25
$53.00M
derived: sum of 2 quarters · filed 2023-10-25
$30.00M
10-Q · filed 2023-10-25
$77.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$23.00M
10-Q · filed 2023-07-27
$23.00M
10-Q · filed 2023-07-27
$47.00M
derived: sum of 3 quarters · filed 2024-02-22
$71.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$22.00M
10-Q · filed 2023-04-28
$24.00M
derived: sum of 2 quarters · filed 2024-02-22
$48.00M
derived: sum of 3 quarters · filed 2024-02-22
$68.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$26.00M
derived: sum of 2 quarters · filed 2024-02-22
$46.00M
derived: sum of 3 quarters · filed 2024-02-22
$26.00M
10-K · filed 2024-02-22
2021-09-30$24.00M
10-Q · filed 2022-10-21
$44.00M
derived: sum of 2 quarters · filed 2022-10-21
$24.00M
10-Q · filed 2022-10-21
$65.00M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$20.00M
10-Q · filed 2022-07-22
$20.00M
10-Q · filed 2022-07-22
$41.00M
derived: sum of 3 quarters · filed 2023-02-21
$96.00M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31$30.00M
10-Q · filed 2022-04-22
$21.00M
derived: sum of 2 quarters · filed 2023-02-21
$76.00M
derived: sum of 3 quarters · filed 2023-02-21
$124.00M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31-$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$46.00M
derived: sum of 2 quarters · filed 2023-02-21
$94.00M
derived: sum of 3 quarters · filed 2023-02-21
$46.00M
10-K · filed 2023-02-21
2020-09-30$55.00M
10-Q · filed 2021-10-22
$103.00M
derived: sum of 2 quarters · filed 2021-10-22
$55.00M
10-Q · filed 2021-10-22
$116.00M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$48.00M
10-Q · filed 2021-07-23
$48.00M
10-Q · filed 2021-07-23
$61.00M
derived: sum of 3 quarters · filed 2022-02-28
$85.00M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$11.00M
10-Q · filed 2021-04-23
$13.00M
derived: sum of 2 quarters · filed 2022-02-28
$37.00M
derived: sum of 3 quarters · filed 2022-02-28
$52.00M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$26.00M
derived: sum of 2 quarters · filed 2022-02-28
$41.00M
derived: sum of 3 quarters · filed 2022-02-28
$26.00M
10-K · filed 2022-02-28
2019-09-30$24.00M
10-Q · filed 2020-10-23
$39.00M
derived: sum of 2 quarters · filed 2020-10-23
$24.00M
10-Q · filed 2020-10-23
$50.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-06-30$15.00M
10-Q · filed 2020-07-24
$15.00M
10-Q · filed 2020-07-24
$26.00M
derived: sum of 3 quarters · filed 2021-02-22
$39.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-03-31$13.00M
10-Q · filed 2020-05-04
$11.00M
derived: sum of 2 quarters · filed 2021-02-22
$24.00M
derived: sum of 3 quarters · filed 2021-02-22
$37.00M
derived: sum of 4 quarters · filed 2021-02-22
2018-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22
$11.00M
derived: sum of 2 quarters · filed 2021-02-22
$24.00M
derived: sum of 3 quarters · filed 2021-02-22
$11.00M
10-K · filed 2021-02-22
2018-09-30$13.00M
10-Q · filed 2019-10-23
$26.00M
derived: sum of 2 quarters · filed 2019-10-23
$13.00M
10-Q · filed 2019-10-23
$54.00M
derived: sum of 4 quarters · filed 2020-02-20
2018-06-30$13.00M
10-Q · filed 2019-07-24
$13.00M
10-Q · filed 2019-07-24
$41.00M
derived: sum of 3 quarters · filed 2020-02-20
$55.00M
derived: sum of 4 quarters · filed 2020-02-20
2018-03-31$16.00M
10-Q · filed 2019-04-24
$28.00M
derived: sum of 2 quarters · filed 2020-02-20
$42.00M
derived: sum of 3 quarters · filed 2020-02-20
$55.00M
derived: sum of 4 quarters · filed 2020-02-20
2017-12-31$12.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20
$26.00M
derived: sum of 2 quarters · filed 2020-02-20
$39.00M
derived: sum of 3 quarters · filed 2020-02-20
$26.00M
10-K · filed 2020-02-20
2017-09-30$14.00M
10-Q · filed 2018-10-24
$27.00M
derived: sum of 2 quarters · filed 2018-10-24
$14.00M
10-Q · filed 2018-10-24
$37.00M
derived: sum of 4 quarters · filed 2019-02-21
2017-06-30$13.00M
10-Q · filed 2018-07-25
$13.00M
10-Q · filed 2018-07-25
$23.00M
derived: sum of 3 quarters · filed 2019-02-21
$34.00M
derived: sum of 4 quarters · filed 2019-02-21
2017-03-31$12.00M
10-Q · filed 2018-04-20
$10.00M
derived: sum of 2 quarters · filed 2019-02-21
$21.00M
derived: sum of 3 quarters · filed 2019-02-21
$33.00M
derived: sum of 4 quarters · filed 2019-02-21
2016-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
$9.00M
derived: sum of 2 quarters · filed 2019-02-21
$21.00M
derived: sum of 3 quarters · filed 2019-02-21
$9.00M
10-K · filed 2019-02-21
2016-09-30$11.00M
10-Q · filed 2017-10-19
$23.00M
derived: sum of 2 quarters · filed 2017-10-19
$11.00M
10-Q · filed 2017-10-19
$40.00M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$12.00M
10-Q · filed 2017-07-25
$12.00M
10-Q · filed 2017-07-25
$29.00M
derived: sum of 3 quarters · filed 2018-02-23
$40.00M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$13.00M
10-Q · filed 2017-04-21
$17.00M
derived: sum of 2 quarters · filed 2018-02-23
$28.00M
derived: sum of 3 quarters · filed 2018-02-23
$37.00M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$15.00M
derived: sum of 2 quarters · filed 2018-02-23
$24.00M
derived: sum of 3 quarters · filed 2018-02-23
$15.00M
10-K · filed 2018-02-23
2015-09-30$11.00M
10-Q · filed 2016-10-21
$20.00M
derived: sum of 2 quarters · filed 2016-10-21
$11.00M
10-Q · filed 2016-10-21
$45.00M
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30$9.00M
10-Q · filed 2016-07-25
$9.00M
10-Q · filed 2016-07-25
$34.00M
derived: sum of 3 quarters · filed 2017-02-22
$46.00M
derived: sum of 4 quarters · filed 2017-02-22
2015-03-31$11.00M
10-Q · filed 2016-04-27
$25.00M
derived: sum of 2 quarters · filed 2017-02-22
$37.00M
derived: sum of 3 quarters · filed 2017-02-22
$51.00M
derived: sum of 4 quarters · filed 2017-02-22
2014-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22
$26.00M
derived: sum of 2 quarters · filed 2017-02-22
$40.00M
derived: sum of 3 quarters · filed 2017-02-22
$26.00M
10-K · filed 2017-02-22
2014-09-30$12.00M
10-Q · filed 2015-10-29
$26.00M
derived: sum of 2 quarters · filed 2015-10-29
$12.00M
10-Q · filed 2015-10-29
$55.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$14.00M
10-Q · filed 2015-07-30
$14.00M
10-Q · filed 2015-07-30
$43.00M
derived: sum of 3 quarters · filed 2016-02-26
$49.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$7.00M
10-Q · filed 2015-04-30
$29.00M
derived: sum of 2 quarters · filed 2016-02-26
$35.00M
derived: sum of 3 quarters · filed 2016-02-26
2013-12-31$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$28.00M
derived: sum of 2 quarters · filed 2016-02-26
$28.00M
10-K · filed 2016-02-26
2013-09-30$6.00M
10-Q · filed 2014-10-30
$6.00M
10-Q · filed 2014-10-30
2012-12-31$0.00
10-K · filed 2015-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30